Article

LncRNA antigens - a novel resource to improve immunotherapy efficacy predictions in melanoma

2025-06-30

Abstract excerpt

<h4>Background: </h4> ICI (immune checkpoint inhibitor) therapeutic response for melanoma varies among patients, emphasizing the importance of identifying genomic biomarkers to predict efficacy in advance of treatment. We hypothesised that a lncRNA based immunogenicity (lnc-IM) score could be used to predict individual response to ICI treatment, and that this could complement the existing criterion for ICI selecti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f4e98ae6-eb17-5f11-acfc-b74e04ffe1ea
DOI: 10.12688/hrbopenres.14141.1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

LncRNA antigens - a novel resource to improve immunotherapy efficacy predictions in melanomaDOI 10.12688/hrbopenres.14141.1Read

LncRNA antigens- a novel resource to improve immunotherapy efficacy predictions in MelanomaSemantic proximity Read

Prediction of Immunotherapy Response in Melanoma through Combined Modeling of Neoantigen Burden and Immune-Related Resistance MechanismsSemantic proximity Read

Construction of immune scores to predict patient prognosis and response of anti-PD1 treatment in stage III-IV melanomaSemantic proximity Read

Insights and Strategies of Melanoma Immunotherapy: Predictive Biomarkers of Response and Resistance and Strategies to Improve Response RatesSemantic proximity Read

MHC class I and class II genotypes are independent predictors of anti-PD1 immunotherapy response in melanomaSemantic proximity Read

Integrated genomic analysis identifies a genetic mutation model predicting response to immune checkpoint inhibitors in melanoma.Semantic proximity Read

Integrated germline and somatic features reveal divergent immune pathways driving ICB responseSemantic proximity Read

Explainable machine learning identifies features and thresholds predictive of immunotherapy responseSemantic proximity Read

Construction and validation of an immunoediting-based optimized neoantigen load (ioTNL) model to predict the response and prognosis of immune checkpoint therapy in various cancers.Semantic proximity Read

HLA class II immunogenic mutation burden predicts response to immune checkpoint blockade.Semantic proximity Read

HINS: HLA-mediated immunogenic neoantigen score for robust prediction of immune checkpoint blockade responseSemantic proximity Read

Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma.Semantic proximity Read